Stock Analysis

Curaleaf Holdings Third Quarter 2023 Earnings: Misses Expectations

Simply Wall St

November 14, 2023

Curaleaf Holdings (CSE:CURA) Third Quarter 2023 Results

Key Financial Results

Revenue: US$333.2m (up 2.3% from 3Q 2022).
Net loss: US$69.5m (loss widened by 80% from 3Q 2022).
US$0.096 loss per share (further deteriorated from US$0.054 loss in 3Q 2022).

earnings-and-revenue-growth — CNSX:CURA Earnings and Revenue Growth November 14th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Curaleaf Holdings Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) also missed analyst estimates by 124%.

Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Canada.

Performance of the Canadian Pharmaceuticals industry.

The company's shares are up 2.7% from a week ago.

Risk Analysis

Be aware that Curaleaf Holdings is showing 3 warning signs in our investment analysis that you should know about...

Valuation is complex, but we're helping make it simple.

Find out whether Curaleaf Holdings is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.